Multi-Method Drug Analysis in Human Plasma Using Fault-Tolerant High-Throughput LC-MS/MS System

Importance of the topic

High-throughput, robust, and low-carryover quantitative analysis of drugs in human plasma is critical for forensic toxicology, clinical research, and high-volume laboratory workflows. Traditional single-flow LC–MS/MS approaches are limited by sample carryover, instrument downtime for column and mobile phase exchange, and labor-intensive offline sample preparation. Multiplexed LC–MS/MS architectures with integrated online solid-phase extraction (SPE) can address these bottlenecks by combining parallel analysis streams, selective on-line cleanup, and reduced idle time, enabling greater sample throughput while preserving quantitative performance.

Objectives and study overview

This study evaluated a fault-tolerant, high-throughput LC–MS/MS system designed for simultaneous multi-method analysis of 26 target drugs spiked into pooled human plasma. Key aims were to demonstrate: parallel operation of multiple independent LC streams coupled to a single triple-quadrupole mass spectrometer; compatibility of two orthogonal online SPE chemistries to capture diverse analytes; quantitative linearity and precision across relevant concentration ranges; and net throughput gains relative to a conventional single-method LC–MS workflow.

Methodology

Sample preparation and general workflow:

• Matrix: Pooled human plasma.
• Sample prep: Protein precipitation by adding 300 µL acetonitrile to 100 µL plasma, mixing, centrifugation (10,000 rpm, 10 min), and dilution of supernatant with standards to form QC samples.
• Online SPE: Two SPE chemistries selected to retain complementary compound classes — reversed-phase (C18/ODS) and weak cation exchange (WCX) — allowing selective trapping of analytes prior to transfer to the analytical column.
• Analysis strategy: Four independent LC flow paths (streams) operated in parallel; two streams used ODS SPE and two used WCX SPE to execute two different methods concurrently without exchanging columns or mobile phases.

Instrumentation

• Multiplex LC: Nexera QX system configured with four sets of binary pumps and autosamplers to deliver four isolated flow paths.
• Mass spectrometer: Shimadzu LCMS-8060RX triple-quadrupole MS operated with electrospray ionization (ESI).
• Online SPE columns: MAYI 2 C18-60 (50 × 1.0 mm I.D.) and MAYI 2 WCX (50 × 1.0 mm I.D.).
• Analytical column: Shim-pack Scepter C18-120 (50 × 2.1 mm, 3.0 µm); column temperature 40 °C.
• MS conditions: ESI source; nebulizing gas ~3.0 L/min; drying/heating gas flows and interface/heat block temperatures tuned for robust desolvation (reported DL temp 250 °C, heat block 400 °C, interface 500 °C in the study).
• Software: Centralized control via QX Solution to manage multiplexed operation, valve switching, and synchronization of injection/SPE cycles.

Results and discussion

Method performance:

• Analytes: 26 target drugs spanning multiple classes (opioids, stimulants, benzodiazepines, synthetic cathinones, etc.).
• Linearity: Calibration curves for all compounds showed strong linearity with coefficients of determination r2 > 0.99.
• Quantitative precision and accuracy: Quality control evaluations at two concentration levels demonstrated accuracies within approximately 80–115% for all compounds, meeting typical acceptance criteria for exploratory and many forensic/clinical research applications.
• Dynamic range: Reported calibration ranges covered low-part-per-trillion (ppt) levels up to 10,000 ppt depending on the compound, indicating sensitivity adequate for trace-level monitoring of many drugs.

Operational benefits demonstrated:

• Reduced carryover and cross-contamination due to fully isolated flow paths and dedicated autosamplers per stream.
• Integrated online SPE provided automated matrix cleanup, reducing manual sample handling and mitigating matrix effects while enhancing sensitivity for low-abundance analytes.
• Throughput improvement: A simulation comparing a conventional LC–MS method (approximately 9.3 min per sample) with the multiplexed 4-stream system indicated roughly a 60% increase in sample throughput, achieved by overlapping SPE/trap, elution, gradient separation, wash, and equilibration cycles across streams.

Limitations and considerations:

• Although accuracy and linearity met study criteria, individual compound performance varied; compounds at the extremes of concentration range or with strong matrix interactions may require tailored optimization and validation.
• The system is provided as Research Use Only (RUO); clinical diagnostic implementation would require formal method validation per regulatory standards.

Benefits and practical applications

• High-volume forensic and clinical research labs can process more samples per unit time without compromising quantitative quality, supporting large-scale toxicology surveys, pharmacokinetic screening, and workplace testing programs.
• Reduced maintenance downtime and diminished need for frequent column/mobile-phase swaps lower operational overhead and increase instrument uptime.
• Automated online SPE lowers hands-on sample-prep labor and variability, improving reproducibility across batches.
• Modular multiplexing (multiple streams tied to a single MS) offers fault tolerance: individual stream issues do not necessarily halt the entire analytical throughput.

Future trends and potential uses

• Further multiplexing: Scaling to more streams or integrating staggered injection scheduling could push throughput even higher for very large studies.
• Intelligent scheduling and predictive maintenance: Software-driven optimization (including AI-based scheduling) could maximize instrument utilization and further reduce downtime.
• Hybrid approaches: Combining multiplexed low-volume flow LC with high-resolution MS could extend qualitative screening capabilities while preserving high-throughput quantitation.
• Expanded automation: Integration with robotic sample handling and fully automated plate-to-MS workflows would minimize manual intervention for sample receipt to data generation.
• Regulatory translation: As multiplexed systems demonstrate reproducible performance, standardized validation protocols and guidelines will be needed to support clinical and forensic accreditation.

Conclusion

The described 4-channel multiplexed LC–MS/MS system with orthogonal online SPE chemistries enables simultaneous execution of two distinct methods in parallel, delivering substantial throughput gains (~60% in the authors' simulation) while maintaining strong analytical performance (r2 > 0.99, QC accuracies within typical acceptance ranges). By isolating flow paths and automating SPE trapping/elution, the platform reduces carryover, minimizes downtime associated with method exchanges, and lowers manual sample-prep burden—features attractive for high-volume forensic and clinical research laboratories. Transitioning this RUO configuration into regulated environments will require full, compound-specific method validation and consideration of operational governance.

References

1. Suzuki Y, Imoto E, Miller L, Sato S, Johnson V. Multi-Method Drug Analysis in Human Plasma Using Fault-Tolerant High-Throughput LC-MS/MS System. Shimadzu internal application note / conference presentation. (Research Use Only).